Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Oct 17, 2013 | Director | Form 4 | Open market or private sale of non-derivative or derivative security | 20,000 | $15.06 | 15,850 | |
| Oct 17, 2013 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | -- | -- | |
| Feb 01, 2013 | EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | -- | 20,000 | |
| Oct 18, 2011 | SVP, GM - Vascular | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | -- | 20,000 | |
| Aug 03, 2010 | President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | -- | 117,675 | |
| Aug 03, 2010 | SVP - General Manager | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | -- | 20,000 | |
| Jul 05, 2006 | Director, President & CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | $4.35 | 70,114 | |
| Jul 05, 2006 | Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 20,000 | $26.37 | 50,114 | |
| Jul 05, 2006 | Director, President & CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | -- | 64,082 | |
| Jun 01, 2006 | Director, President & CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | $4.35 | 70,114 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.